Dr Reddy's falls on concerns Q3 results may miss estimates

Shares in Dr Reddy's Laboratories fall 2.1 percent on worries the drug maker will post lower-than-expected October-December earnings, due later in the day.

Margins are also expected to see significant erosion, several dealers add.

Dr Reddy's could miss consensus earnings per share (EPS) estimates by 6 percent in the October-December quarter, according to Thomson Reuters StarMine SmartEstimate data, which measures the forecasts from top-ranked analysts against wider forecasts. * StarMine SmartEstimate suggests EPS for the quarter ending December at Rs 26.03 compared with mean estimate of Rs 27.89.

Anda sedang membaca artikel tentang

Dr Reddy's falls on concerns Q3 results may miss estimates

Dengan url

http://kebugaranhidup.blogspot.com/2013/02/dr-reddys-falls-on-concerns-q3-results.html

Anda boleh menyebar luaskannya atau mengcopy paste-nya

Dr Reddy's falls on concerns Q3 results may miss estimates

namun jangan lupa untuk meletakkan link

Dr Reddy's falls on concerns Q3 results may miss estimates

sebagai sumbernya